Jump to content

Search the Community

Showing results for tags 'lutetium-177'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • COMMUNITY
    • Announcements, meetings and other resources
  • ADVANCED PROSTATE CANCER FORUMS
    • Primary hormone therapy
    • Secondary hormone therapy
    • Castrate Resistant Prostate Cancer
    • Metastatic
    • Very high risk
    • New agents
    • Every little bit helps
    • Radiation, diagnostic imaging, bones and other prostate cancer topics
    • Articles on other sites
  • MEMBER'S STORIES AND NEEDS
    • My story
    • Any suggestions?
    • The lounge

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Found 4 results

  1. Jim Marshall (not a doctor) said ... A number of our members participated in this first trial of using radioactive Lutetium (Lutetium-177, Lu-177) for men who had already had several other treatments. This is the latest report, quoting the study leader, Michael Hofman at Peter McCallum (PeterMac) in Melbourne. After you read the article, if you want to find out what our members might have said about their Lutetium treatment, go to the Search... box near the top of this page and type: Lutetium ... end Jim https://www.healio.com/hematology-oncology/prostate-cancer/
  2. Jim Marshall (not a doctor) said ... PSMA (Prostate Specific Membrane Antigen) is a molecule found naturally in the body. PSMA is often found in great numbers on the surface of prostate cancer cells. Doctors are currently running trials attaching radioactive molecules to the PSMA molecule. Some radioactive molecules are picked because they light up on a PET scan. Such scans are often called PSMA scans. The best known in Australia is the Gallium-68 PET/CT scan. Some radioactive molecules are picked because they cause damage to nearby cells. The best known in Austra
  3. MOVEMBER funding will assist Professor Hofman to continue his ground breaking research into Prostate Cancer treatments using Lutetium177 in conjunction with a number of other new compounds. Please support this work - its for our benefit. Click this link https://tinyurl.com/y42kk887 to contribute. Every little bit helps - this is an opportunity for you to show your support for the research being done by Prof Michael Hofman at Peter Mac. Tax deductible receipt issued when you make your contribution or emailed to you by movember. Cheers Barree
  4. An interesting account by Professor Michael Hofman at the Advanced Prostate Cancer Consensus Conference in Basel, Switzerland recently. He speaks of the Lutetium-177 (Lu-177) treatment his team and others have done or are planning: https://www.urotoday.com/video-lectures/apccc-2019-conference/video/1467-players-brightcove-net2019-09-10-14-49-08.html Below the video is a full transcript - all the words Professor Hofman says in the video. Thanks to Nev and Lorraine
×
×
  • Create New...